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Sodium Magnetic Resonance Imaging of
Chemotherapeutic Response in a Rat Glioma
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Surabhi Sharma, Mahesh Kumar, and Jadranka Stojanovska
This study investigates the comparative changes in the sodium
MRI signal and proton diffusion following treatment using a 9L
rat glioma model to develop markers of earliest response to
cancer therapy. Sodium MRI and proton diffusion mapping
were performed on untreated (n  5) and chemotherapy 1,3-
bis(2-chloroethyl)-1-nitrosourea-treated rats (n  5). Animals
were scanned serially at 2- to 3-day intervals for up to 30 days
following therapy. The time course of Na concentration in a
tumor showed a dramatic increase in the treated brain tumor
compared to the untreated tumor, which correlates in time with
an increase in tumor water diffusion. The largest posttreatment
increase in sodium signal occurred 7–9 days following treat-
ment and correlated to the period of the greatest chemothera-
py-induced cellular necrosis based on diffusion and histopa-
thology. Both Na MRI and proton ADC mapping revealed early
changes in tumor sodium content and cellularity. This study
demonstrates the possibility of Na MRI to function as a biomar-
ker for monitoring early tumor treatment and validates the use
of monitoring changes in diffusion MRI values for assessing
tumor cellularity. Magn Reson Med 53:85–92, 2005. © 2004
Wiley-Liss, Inc.
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Sodium MRI is becoming increasingly attractive as a po-
tential marker of anticancer therapeutic response by virtue
of characterization of cellular properties distinct from
those represented on proton MRI. Sodium investigations
also benefit from a better understanding of tumor micro-
environment (1–5) and advances in MRI technique and
high magnetic field technology, which allow application
to humans (6–15).
In our study we investigated the sequence of changes in
the Na MRI signal in a brain tumor model following ap-
plication of a therapeutic agent, with the objective of eval-
uating sodium MRI as biomarker of tumor treatment re-
sponse. Moreover, diffusion mapping was also performed
since it has been shown that an increase in water diffusion
values occurs early following treatment due to loss of cell
membrane integrity and decreased cellularity prior to tu-
mor shrinkage (16,17). The underlying hypothesis of the
detected increase in diffusion is based on therapy-induced
cell destruction leading to a relative increase in water
mobility. Given the normal trans-membrane cellular so-
dium gradient it would be expected that the tumor sodium
signal would also exhibit a temporal change following
effective therapy.
Intracellular Na concentration is 15 mM, while extra-
cellular Na concentration is 140 mM. Consequently, dur-
ing complete cell destruction a large increase in Na tumor
content may take place. Based on the above values along
with the fact that the extracellular space is 0.15 of the
total water space in brain, there can be theoretically an
increase in Na level up to 4 times. An increase of up to
approximately 1.5 times relative to normal brain was de-
tected in study of human brain tumors (14). An increase of
up to 1.8 times relative to pretreatment Na concentration
was found in a radiation-treated C6 rat glioma model (18).
Elevation of tumor Na concentration and ADC increase
during treatment may be related, but at the same time
sodium may yield more functional cellular information
(19–22) as sodium tissue concentration may experience
changes during interventions without any cellular mem-
brane destruction. Thus, the ultimate goal of the present
study was to investigate the relationship between the evo-
lution in tumor sodium and tumor water diffusion using
the 9L rat brain tumor model in response to the chemo-




Rat 9L gliosarcoma cells (Brain Tumor Research Center,
UCSF) were maintained and grown as monolayer cultures
in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% (v/v) heat-inactivated fetal bovine se-
rum, 100 IU/mL penicillin, and 100 g/mL streptomycin
at 37°C in a normally humidified atmosphere containing
95% air/5% CO2. Prior to implantation, cells were grown
to confluence in a 175-cm2 flask and harvested using a
0.25% trypsin/0.1% EDTA solution and counted. Cells
were pelleted (800  g, 5 min) and resuspended in serum-
free DMEM at a concentration of 105 cells/10 L and
kept on ice until use. Cell culture reagents were obtained
from Invitrogen Life Technologies (Carlsbad, CA).
Tumor Implantation of Animals
Male Fisher 344 rats were obtained at 6–7 weeks of age
(116–135 g) from Harlan (Indianapolis, IN). Animals (n 
10) were anesthetized by intraperitoneal injection using an
87%/13% (v/v) ketamine/xylazine mixture and then se-
cured in a stereotactic head frame. In aseptic conditions,
using a No. 10 scalpel, an incision (2 cm) was made to
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expose the skull and a 0.9-mm-diameter burr hole was
drilled over the right forebrain using a high-speed drill
(FST, Foster City, CA). For each animal, 10 L of 9L cells
(105 cells) were injected at a depth of 2.5 mm. The
surgical field was then cleansed using 70% ethanol and
the burr hole was filled with bone wax to minimize extra-
cerebral growth of the tumor.
Chemotherapeutic Treatment
Seventeen days after the tumor implantation, 10 tumor-
bearing rats were divided into two groups of 5 (treated and
control). The treated group received BCNU therapy. The
average size of the tumor at the moment of treatment was
50 L. Standard 100 mg BCNU preparation (Bristol Lab)
was dissolved in 3 mL of ethanol. Part of this solution
(0.3 mL) was dissolved in 2.7 mL of saline and immedi-
ately used for IP injection (1.3 mL). The BCNU dose of
injection was 26.6 mg/kg, which is equivalent to double an
LD10 dose. All animal experiments were conducted ac-
cording to the protocols approved by the University of
Michigan Committee on Use and Care of Animals.
Three additional normal rats served as a second control
to evaluate possible changes in brain Na concentration
during animal aging and stability of Na MR signals during
the 50-day interval of these experiments.
MR Imaging
Sodium and proton MRI were performed periodically on
all animals to follow the full course of tumor growth be-
yond date of treatment until sacrifice. Proton and sodium
MR scans have been performed on two different scanners
and the animals had to be repositioned between proton
and sodium acquisitions. One system (9.4-T Varian MR
scanner, 120-mm clear horizontal bore) was configured for
all sodium scans, and an adjacent system (7-T Varian MR
scanner, 110-mm clear horizontal bore) was used for all
proton MRI. For every given tumor-bearing animal and a
time point, the interval between sodium and proton acqui-
sitions was approximately 1 hr, and each animal was
scanned every 2 to 3 days. The same imaging protocol was
used for normal rats without tumor (n  3), but these were
scanned only once per week over a 50-day period. With
the purpose of helping the animals to support their body
temperature during MRI scan all animals were placed on a
temperature-controlled circulating-water heating pad. An-
esthesia was achieved by breathing of 1% v/v isoflu-
rane/air gas mixture.
Sodium MRI
The tumor region of the rat brain was placed near the
center of the homebuilt Na RF coil having an internal
diameter of 32 mm and length of 45 mm. Rat heads were
positioned in the RF coil to within 1 mm using the eyes
as reference points. The axial length of the RF homogenous
region (6%) was approximately 14 mm, which was suf-
ficient to encompass the spatial extent of the tumors and
allow quantitative tumor sodium imaging. Because so-
dium has short T2 relaxation time components, a 3D back-
projection pulse sequence was used. The concept of the
back-projection MR imaging was first suggested by Lauter-
bur in 1973 (23). The original spin-echo 3D back-projec-
tion pulse sequence (Varian, Inc.) included two hard
pulses and provided an echo time of 500 sec. The other
parameters were: readout gradient 1.3 G/cm, FOV 64 
64  64 mm, acquisition matrix 32  32  32, TR 
0.1 sec, and scan time  30 min. Duration of the 90° pulse
was 50 sec. Sodium T1 relaxation time in normal rat
brain in our experiments was 38.1  1.5 msec at 9.4 T, thus
yielding almost unsaturated Na signal during 3D imaging.
Back-projection reconstruction was performed using ven-
dor-provided software with zero-filling to give a matrix of
128  128  128 voxels for the sodium signal through the
rat brain.
Proton MRI
Protocol for proton MRI included proton T2-weighted FSE
and diffusion weighted multislice scans with total scan
time of 26 min. Parameters for FSE scan were: FOV 30 
30 mm, matrix 128  128, 13 slices, slice thickness 1 mm,
interslice distance 1.5 mm, TR  6 sec, TEeff  60 msec,
and echo train length  8. Parameters for the diffusion
scan were: FOV 30  30 mm, matrix 128  128, 13 slices,
slice thickness  1 mm, interslice distance  1.5 mm, spin
echo with TR  3 sec, and TE  60 msec. The diffusion
sequence employed isotropic diffusion weighting by or-
thogonalization of x-, y-, and z-gradient waveforms. That
is, imaging plus diffusion gradient waveforms were de-
signed to equalize diagonal elements and zero out off-
diagonal elements of the b-matrix. In addition, this se-
quence included first-order motion compensation and a
32-point navigator echo for phase-correction prior to 2DFT
image reconstruction. Diffusion weighted images (DWI) at
two-b-factor settings were acquired for calculation of an
ADC map: “high-b” (b  1082 sec/mm2) and “low-b” (b 
117 sec/mm2). Proton images and ADC maps were recon-
structed in Matlab and the tumor volume and tumor aver-
age ADC were determined over a 3D VOI for each temporal
measurement.
Quantification and Analysis
Three-dimensional sodium and multislice proton (FSE T2-
weighted, DWI, and ADC) were coregistered in three di-
mensions, wherein the “deviant” sodium MRI image set
undergoes rotate-translate transform onto the “target” pro-
ton image set. In our experiments, the proton T2-weighted
MRI was used as the main registration target. This process
puts all images into a common geometrical frame such that
tumor VOI definition is performed on available higher
quality images yet is directly applicable to quantitative
images of interest (i.e., sodium and ADC).
The quantification of Na MRI data was performed as
follows. Na MRI measurement of the normal rat brain
(three rats, eight MRI sessions) gave the amplitude aver-
aged over 24 measurements. This average amplitude was
assigned to 45 mM, as this value for normal rat brain was
already found and published by others (18,24).
Then, the values of the tumor Na signal obtained at the
time point “0” (i.e., immediately before BCNU injection or
17 days after tumor implantation) from all 10 tumor-bear-
ing animals were also averaged. This average amplitude
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was compared with the average amplitude from the nor-
mal rats and the comparison gave us the initial tumor Na
concentration at day 0 of 60 mM. This average tumor
signal and the first measurements for each animal at day 0
were used to obtain the normalizing factor for this animal
at zero and other time points. This step was introduced to
partially offset any possible variation in intensity 10%
due to deviations in the tumor positions of individual
animals inside the RF coil. Thereafter, all tumor Na signals
were compared with Na signals from a normal rat brain to
obtain tumor Na concentration values in millimoles.
Reproducibility of the experimental conditions for so-
dium imaging was periodically checked using three non-
tumored rats and will be demonstrated later in the paper.




The typical sodium and proton images for the matching
slice position in a normal rat brain are presented in Fig. 1.
The sodium image clearly depicts the rat head and brain.
The outline of the brain from the proton image is scribed in
red and overlaid on the sodium image. The color bar for
the sodium images was selected from the maximum ob-
served tumor Na signals, which gave for the normal rat
brain Na intensity around 45%. This color scale is held
constant for all subsequent Na images to visually demon-
strate absolute change in brain Na concentration over time
following therapy.
The sodium signal intensities in normal rat brain inte-
grated over the region corresponding to tumor in tumor-
bearing animals show a reproducibility of sodium mea-
surements in our system. These sodium signals averaged
from three normal animals studied over 50 days of our
experiments are plotted in Fig. 2. The Na MRI signals from
the normal rat brain were extremely reproducible and
remained unchanged throughout all days of the experi-
ments. The SD of sodium MRI measurements in normal rat
brain was 4%.
Untreated Brain Tumor
Examples of images from untreated tumor-bearing animals
are presented in Fig. 3. The upper row depicts Na images;
below are corresponding proton ADC maps. Images in Fig.
3 were acquired at 0, 4, and 7 days. Day 0 corresponds to
day 17 after 9L tumor cell implantation. The contour lines
on sodium images show the position of the tumor deter-
mined from proton MR images. Tumor sodium intensities
on the images are increasing in time and are distinctive
from the normal brain. As can be seen in Fig. 3 the Na
signals are heterogeneous throughout the tumor. On day 7,
the untreated animals were sacrificed due to the large
tumor size. Even at this time, the distribution of the Na
signals remained heterogeneous. It is important to notice
that at the rim of tumor a Na concentration was usually the
lowest, while areas of high concentration of Na may reflect
the location of areas with high intracellular Na concentra-
tion and/or regional necrosis. The untreated group of rats
had an average survival time of 7 days (or 24 days from 9L
cell implantation).
BCNU-Treated Brain Tumor
The effects of BCNU treatment on the tumor are demon-
strated in Fig. 4. As for the untreated rats, a heterogeneous
Na concentration can be seen throughout the tumor on the
start day (day 0). The middle images were taken at day 7
following BCNU treatment. At this time an intense in-
FIG. 1. Sodium MRI (right) and
proton ADC map (left) MR for the
matching slice position in a nor-
mal rat brain. Color bar gives the
intensity scale, which is held con-
stant for all sodium images to vi-
sually demonstrate absolute al-
terations in brain Na concentra-
tions with time following therapy.
FIG. 2. Sodium MRI concentration in the normal rat brain. There
was no significant trend detected over the 50-day monitoring period
(n  3). Day 0 corresponds to the time of BCNU injection in the
treated group.
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crease in Na concentration in all areas of the tumor was
observed, including the rim of the tumor, and the corre-
sponding largest increase in ADC of water in the tumor
was detected. During tumor regrowth, sodium concentra-
tions were reduced and heterogeneity in tumor Na reap-
peared, as shown in images acquired on day 23. Average
survival time of the treated group was 28 days (or 45 days
from tumor implantation).
ADC Map
Example of ADC maps showing changes of in tumor dif-
fusion values are shown in the bottom row of Figs. 3 and 4.
The matching slice positions illustrate a good correspon-
dence in features between ADC map and sodium images.
ADC maps reveal the location of necrosis within the tu-
mor. These areas also correlate with the areas of increased
Na concentration on corresponding Na images.
Increased ADC values and much more homogeneity in-
side the tumor were observed in treated animals, which
have a strong correspondence to the areas of intense Na
concentration on sodium images.
Tumor Sodium Concentration
The time course of the average sodium concentration in
BCNU-treated and untreated brain tumors are given in
Fig. 5. Zero time corresponds to the time immediately
prior to BCNU treatment. The tumor sodium concentration
in untreated rats rose steadily with a rate of 1.6 mM/day.
At the day of sacrifice the maximum tumor Na concentra-
tion was 79 mM or 1.8 times more than in a normal rat
brain.
However, the rate of sodium increase in BCNU-treated
animals was 2.9 times greater (4.7 mM/day). By day 4,
the average Na concentrations in the treated animal group
were statistically higher than in the untreated group. Tu-
mor sodium reached its maximum of 100 mM, which was
2.2 times more than in a normal brain, at day 7 after
treatment. The subsequent decrease in average Na concen-
tration was correlated with tumor shrinkage. During tumor
regrowth, the values of Na signals were comparable to that
in tumors of untreated animals.
ADC and Tumor Volume
The time course of ADC and tumor volume in BCNU-
treated 9L rat brain tumors is illustrated in Fig. 6. A well-
distinguished increase in ADC indicates a positive thera-
peutic response. At day 4 after treatment, ADC values were
statistically significant from the untreated group and
reached maximum change at day 9, with subsequent tumor
shrinkage occurring at day 11. During tumor regrowth,
FIG. 3. Untreated 9L rat brain glioma. So-
dium MRI (top) and proton ADC map (bot-
tom) images acquired at days 0, 4, and 7
(left to right). Day 0 corresponds to the 17th
day from tumor implantation. Sodium im-
ages illustrate a common feature for all un-
treated animals: heterogeneity in tumor Na
concentration and increase of tumor Na
concentration with time.
FIG. 4. BCNU-treated 9L rat glioma. So-
dium MRI (top) and proton ADC maps (bot-
tom) acquired at day 0, 7, and 23 (left to
right) after BCNU injection, performed at
the 17th day from tumor implantation. Cen-
tral Na image at day 7 illustrates the main
feature for all treated animals: a dramatic
Na concentration increase observed
throughout the entire tumor area. The im-
ages at day 23 show tumor during regrowth
after tumor shrinking started at day 9 and
its maximum regression at day 16.
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ADC values decreased and became comparable with the
values for untreated (or pretreated) tumor.
The brain water ADC values of normal animals were
measured weekly as shown at the bottom of Fig. 6. The
average value of ADC in normal rats was (0.78  0.01) 
103 mm2/sec.
The time course for ADC, sodium concentration, and
tumor volumes in untreated animals is given in Fig. 7. No
significant changes in ADC were detected during all the
time of measurements in an untreated tumor while the
tumor was constantly growing. During the same time, a
steady increase in average Na tumor concentration was
observed as shown in Na images (Fig. 3).
DISCUSSION
The objective of this work was to evaluate sodium MRI as
a noninvasive marker of tumor response to anti-cancer
therapy, as well as to correlate changes in sodium with
water diffusion since the use of ADC maps has been stud-
ied extensively in preclinical studies (16,17,25). To ad-
dress these objectives, the natural evolution of sodium
signals in the brain of untreated tumor-bearing animals
was determined and compared to that of treated animals.
The rationale for investigating sodium changes relates to
the sodium concentration gradient, which exists between
intra- and extracellular environments. This concentration
gradient consists of an approximately 10-fold sodium con-
centration difference in the extracellular space relative to
the intracellular space. Disruption of membrane and con-
sequently the change of trans-membrane Na gradient by
way of therapies should be observed as an increase in
sodium signal as a relative shift occurs to a greater volume
with a higher Na concentration. An analogous principle is
the basis for use of water diffusion as a therapy response
indicator, when changes in tumor cellularity increase dif-
fusion. Here, however, the probe is water mobility, which
is greater in the extracellular domain.
Sodium images of the untreated rat brain tumor had
demonstrable heterogeneity. The areas with the largest Na
intensity have a well-defined correspondence to the high
values of ADC in proton images. Within 2 to 5 days fol-
lowing BCNU treatment, increases in tumor Na concentra-
tion were observed. If we compare sodium images for
untreated and treated animals (Figs. 3 and 4) the Na signal
throughout the treated tumor mass increased and became
more uniform relative to the untreated tumor. Moreover,
the changes in tumor Na occurred prior to tumor shrink-
FIG. 5. Time course of tumor sodium concentration in BCNU-
treated (F, n  5) and untreated (f, n  5) 9L rat gliomas. Time 0
corresponds to the day of BCNU treatment (17 days after tumor
implantation). Accelerated rate of Na concentration increase (by 2.9
times) was observed after BCNU treatment in comparison to un-
treated tumors. At the bottom of the graph is the sodium concen-
tration measured in the brain of a normal rat (, n  3).
FIG. 6. Time course of water ADC in tumor (F, n  5) and tumor
volume (▫, n  5) in BCNU-treated rat gliomas. The graph at the
bottom shows ADC measurement of normal rat brain (E, n  3).
Values of ADC during tumor growth and regrowth remain signifi-
cantly above the values for normal brain. Day 0 represents the time
of BCNU injection.
FIG. 7. Comparison of the time course for tumor Na concentration,
ADC of water in the tumor, and tumor volume in untreated rat glioma
model (n  5). Day 0 corresponds to the 17th day from tumor
implantation.
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age, which reveals that Na concentrations can be signifi-
cantly altered by successful therapeutic intervention.
If we assumed that only a loss of the trans-membrane Na
gradient was taking place without membrane destruction,
it would have created a different outcome. Sodium and
water usually move in the same direction; consequently,
the movement of water into intracellular space would lead
to cell swelling and to a decrease in ADC values (26–29).
Observation in our case of an increase in tumor Na con-
centration and a simultaneous increase of tumor water
ADC during BCNU treatment is most likely due to loss of
tumor cell membrane integrity and subsequent changes in
tumor due to efficacious treatment.
Many chemotherapeutic agents act by induction of cel-
lular necrosis, which leads to an inability of the cell mem-
brane to maintain its sodium homeostasis. In addition,
apoptosis may occur, which is characterized by large cell
volume reduction and chromatin condensation (30). Anti-
cancer drug-induced ionic elevations may be closely re-
lated with apoptotic changes (31). Sodium overload may
have a strong connection with apoptosis and even initiate
apoptosis itself, as demonstrated recently (32,33). Thus,
the observed intensive sodium uptake following BCNU
treatment is reflective of the significant loss of Na ho-
meostasis by corresponding loss of cell membrane integ-
rity due to necrotic and/or apoptotic pathways.
Temporal curves in Fig. 8 indicate that there is a strong
correlation between sodium and water diffusion proper-
ties in the tumor following therapy. Overlay of the time
course of Na tumor MRI signals and ADC values in BCNU-
treated 9L glioma (Fig. 8) reveals a very close relationship
following BCNU treatment. Correlation of the tumor Na
and ADC for the period of BCNU effect is given in Fig. 9.
These results present strong evidence for the hypothesis
that the ADC rise during positive tumor treatment corre-
lates with Na signal growth and with corresponding tumor
cell destruction.
Both Na concentration and changes in ADC values in the
treated group were statistically different from untreated
group at day 4 after BCNU treatment. Tumor regression
was observed on average at day 11 posttreatment. Thus,
both Na MRI and ADC were capable of predicting early
positive response to anti-cancer therapy 7 days prior to
tumor shrinkage.
Sodium MRI and ADC methods reflect the same cell
destruction in the tumor during treatment, yet they detect
different properties. Some confirmation of the differences
can be seen at the time of tumor regrowth at day 20 and
beyond (Fig. 8). ADC returned to pretreatment values as
cell membranes regrow and restore additional barriers for
water diffusion. At this time, sodium concentrations in the
tumor remained higher than pretreatment values, but were
similar to the Na content in untreated tumors of the same
size (Fig. 5).
The overlay of the time course for Na tumor MRI signals
and ADC in untreated 9L rat brain tumors demonstrates
more clearly the differences between Na MRI and ADC
(Fig. 7). No significant changes in ADC can be seen in the
untreated tumor over time, while the Na MRI signal in-
creases progressively. This increase in sodium was
steadily observed over time with approximately the same
rate for both small and large untreated tumors. Thus, the
Na signal increase appears unlikely to be solely the result
of a partial volume effect. Similar changes in tumor so-
dium content were also observed earlier in untreated C6
rat glioma (18). We speculate that most likely two possible
yet differing processes can be present simultaneously in
untreated tumors. In one process the increase of tumor
intracellular Na occurs without cellular destruction. Dur-
ing the other process an increase in Na tissue content
occurs as a result of cell destruction due to a partial ne-
crosis (34). Both processes increase Na tumor content but
changes of ADC occur in an opposing direction. Thus, a
combined effect of two processes can explain the observed
Na increase in untreated tumor without changes in ADC,
FIG. 9. Correlation of tumor Na and ADC in the 9L rat glioma from
data obtained at various time points following a single dose of
BCNU (y  12.7  73.7x, R  0.990).
FIG. 8. Comparison of the time dependence of tumor Na concen-
tration (F), ADC of water in the tumor (E), and tumor volume (▫) in a
BCNU-treated rat glioma model (n  5). Tumor shrinking, statisti-
cally observed at day 11, can be predicted a week in advance from
an increase in both Na MRI and ADC beginning at day 4 from BCNU
chemotherapy.
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as in our experiments the average whole tumor Na con-
centrations were contrasted to the average ADC values of
the tumor.
Tumor cellular changes during BCNU treatment in our
9L rat glioma model was presented in a previous publica-
tion (25). From a histologic study during 2  LD10 BCNU
treatment, after 9 days cellular density decreased to 25%
of the pretreatment value, indicating that approximately
75% of the cells were lost due to chemotherapy destruc-
tion. If normal brain has 45 mM Na concentration, the
range of possible Na concentrations is 45 to 140 mM. Thus,
we can estimate the degree of cell destruction from sodium
data. From our Na MRI data it follows that the Na concen-
tration may be increased in the treated tumor up to 2.2
times relative to the normal brain (i.e., 100 mM). There-
fore, we can estimate that in a treated tumor 66% of the
brain tumor cells lost Na trans-membrane gradient. This
level could be the upper limit of cell destruction as we did
not take into consideration that some part of tumor cells
can have an increase in intracellular Na without cell de-
struction. In any case, sodium MRI data correspond rea-
sonably well to the histopathologic decrease in cell den-
sity.
The determined values for cell destruction (66–75%)
represent tumor cell death at day 7 following the start of
BCNU treatment. In our experiments cell kill was deter-
mined to be 1.6, which corresponds to 97% tumor cell
destruction (35). However, the parameters “cell destruc-
tion” and “cell kill” represent cell changes at different
times. Sodium MRI data give information about tumor cell
destruction at day 7, while cell kill gives an integrative
effect of the BCNU treatment over the course of the entire
experimental period.
CONCLUSION
Sodium MRI revealed an increase in Na tumor content
following BCNU treatment that correlated with an ADC
increase in the 9L rat glioma model. Na tumor content is
heterogeneous in all stages of tumor growth in untreated
tumors, reflecting the intratumor heterogeneity of gliomas
and the presence of spontaneous necrosis. BCNU chemo-
therapy initiates an intensive tumor Na increase, which
reflects a dramatic loss of Na trans-membrane gradient by
cell destruction, resulting from a positive response to ther-
apy. Both Na MRI and ADC showed the possibility of early
prediction of positive therapy a week in advance in the
present experiments.
BCNU, along with many other chemotherapeutic agents
and radiation, is capable of initiating cellular necrosis and
apoptosis, which are intermediate steps toward tumor
mass shrinkage. Unfortunately, few methods can accu-
rately quantify necrosis and apoptosis in vivo. Timely in
vivo detection of tumor cell destruction is critically im-
portant for evaluating anti-cancer therapies. The intensive
sodium uptake during BCNU treatment observed in this
study may provide an important tool for detecting the
efficacy of therapy and validates the use of proton ADC
mapping for assessing tumor cellularity.
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